Expression of co-stimulators CD28/B7-1 in peripheral blood of patients with breast cancer-Reference-Cited by-同舟云学术

Expression of co-stimulators CD28/B7-1 in peripheral blood of patients with breast cancer

Published:2012-09-28 Issue:2 Volume:136 Page:621-622
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Gong Jian,Pan Wen,Yang Chuanjia,Guo Feng,Sun Yunping

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-012-2267-2.pdf

Reference3 articles.

1. Quintayo MA, Munro AF, Thomas J et al (2012) GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients. Breast Cancer Res Treat. doi: 10.1007/s10549-012-2229-8

2. Burnet FM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13:1–27

3. Rabinowich H, Reichert TE, Kashii Y et al (1998) Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest 101:2579–2588

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple‐negative breast cancer;Journal of Surgical Oncology;2024-06-06

2. The effect of CTLA-4 and CD28 gene variants and circulating protein levels in patients with gastric cancer;Turkish Journal of Biochemistry;2017-01-01

3. SNP–SNP interactions of immunity related genes involved in the CD28/B7 pathway with susceptibility to invasive ductal carcinoma of the breast;Gene;2015-07

4. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome–wide interaction study;Endocrine-Related Cancer;2013-09-30